Skip to main content
. Author manuscript; available in PMC: 2021 Jun 2.
Published in final edited form as: Vaccine. 2020 May 7;38(27):4221–4225. doi: 10.1016/j.vaccine.2020.04.069

Table 2.

HAI Responders versus Alternate responders versus No response

PCR-positive HAI respondersa (n=117) PCR-positive HAI non-respondersa with alternate responseb (n=18) PCR-positive No response (n=14) P-value

Male 52 (44%) 6 (33%) 8 (57%) 0.4037
Age 0.4248
0–14 years 79 (68%) 12 (67%) 7 (50%)
15+ years 38 (32%) 6 (33%) 7 (50%)
Symptoms
Feverc 99 (85%) 13 (72%) 9 (64%) 0.1070
ILId 95 (81%) 13 (72%) 7 (50%) 0.0274
ARIe 108 (92%) 15 (83%) 8 (57%) 0.0006
Illness duration (mean days, SD)
Cough 7.39 (3.54) 6.14 (4.00) 5.41 (4.49) 0.0933
Shedding 4.23 (3.07) 3.72 (2.87) 2.71 (1.90) 0.1732
Pre-exposure antibody levels (mean level, SD)
HAI 11.41 (16.28) 5.27 (1.18) 19.23 (28.64) 0.0757
HA full 41.59 (71.69) 38.45 (101.14) 104.78 (99.81) 0.0173
HA stalk 36.57 (54.96) 27.21 (47.57) 116.75 (138.87) 0.0001
NA 13.11 (19.44) 9.90 (8.34) 23.93 (31.88) 0.1131

Data are no. individuals with characteristic/no. of individuals.

Abbreviations: ILI, influenza-like illness; ARI, acute respiratory infection; SD, standard deviation; HAI, hemagglutinin inhibition assay; HA, hemagglutinin; NA, neuraminidase.

a

HAI non-responder is an individual who failed to generate a 4-fold or greater HAI response; HAI responder is an individual who generated a 4-fold or greater HAI response.

b

Alternate response is a 4-fold or greater response to HA full, HA stalk, or NA.

c

Fever is reported fever or measured temperature ≥ 37.5 °C.

d

ILI is fever as described above plus either cough or sore throat.

e

ARI is defined as any of the following symptoms: fever, cough, sore throat, runny nose.